Literature DB >> 8181246

A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy.

S J Benbow1, A W Chan, D Bowsher, I A MacFarlane, G Williams.   

Abstract

Fifty diabetic patients with chronic painful sensorimotor neuropathy were studied prospectively to clarify the natural history of this condition and the roles of small-fibre damage and concomitant peripheral vascular disease (PVD). Initially, 30 patients had no significant PVD (ankle:brachial Doppler ratio > 1.0). Pain was assessed using a visual analogue scale (0-10 cm), and small-fibre function by thermal limen (TL), heat-pain threshold (HPT), and weighted pinprick threshold (PPT). At follow-up, on average 3.6 years later (range 3.0-4.1), 11 patients had died (6 with PVD) and contact had been lost with 6. Pain scores fell in subjects without PVD (n = 24; median (range), from 4.8 (0.5-10.0) to 2.0 (0.0-9.2) cm, p < 0.001) and also in those with PVD (n = 9; from 5.1 (2.0-8.2) to 2.1 (0.0-8.0) cm, p < 0.05). Seven patients (5 without PVD) became painfree; at presentation, these 7 patients had experienced pain for a shorter period of time. Despite this symptomatic improvement, small-fibre function generally deteriorated in both groups, with significant worsening (p < 0.05) of HPT and PPT in patients without PVD, and in HPT and TL in patients with PVD. Neuropathic pain therefore tends to improve with time and can resolve completely. By contrast, small-fibre function continues to deteriorate, indicating that these peripheral measures do not predict the evolution of painful symptoms. The presence or absence of PVD does not appear to affect the natural history of neuropathic pain or its symptomatology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181246     DOI: 10.1111/j.1464-5491.1994.tb00223.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  18 in total

1.  Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain.

Authors:  Jianfei Guo; Xudong Fu; Xia Cui; Minhua Fan
Journal:  J Physiol Sci       Date:  2014-11-01       Impact factor: 2.781

2.  Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain.

Authors:  Andrew M Tan; Omar A Samad; Tanya Z Fischer; Peng Zhao; Anna-Karin Persson; Stephen G Waxman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  Management of painful diabetic neuropathy: what is new or in the pipeline for 2007?

Authors:  Dan Ziegler
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

Review 4.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

5.  Clinical Approach to the Treatment of Painful Diabetic Neuropathy.

Authors:  Alexandra Hovaguimian; Christopher H Gibbons
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

Review 6.  Nociception at the diabetic foot, an uncharted territory.

Authors:  Ernst A Chantelau
Journal:  World J Diabetes       Date:  2015-04-15

Review 7.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

8.  Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.

Authors:  Cory C Toth; Nicole M Jedrzejewski; Connie L Ellis; William H Frey
Journal:  Mol Pain       Date:  2010-03-17       Impact factor: 3.395

Review 9.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 10.  Painful diabetic neuropathy: advantage of novel drugs over old drugs?

Authors:  Dan Ziegler
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.